e-learning
resources
Berlin 2001
Monday 24.09.2001
Issues in lung transplantation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation
P. Vitulo, T. Oggionni, A. Cascina, E. Volpini, E. Arbustini, F. Meloni, A. M. D'Armini, M. Viganò, A. Rossi (Pavia, Italy)
Source:
Annual Congress 2001 - Issues in lung transplantation
Session:
Issues in lung transplantation
Session type:
Thematic Poster Session
Number:
1982
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Vitulo, T. Oggionni, A. Cascina, E. Volpini, E. Arbustini, F. Meloni, A. M. D'Armini, M. Viganò, A. Rossi (Pavia, Italy). Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation. Eur Respir J 2001; 16: Suppl. 31, 1982
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Special issues in elderly people with solitary pulmonary nodule: non intubated thoracic surgery
Lung transplantation
Severe haemoptysis
Related content which might interest you:
Immunosuppressive therapy after human lung transplantation
Source: Eur Respir J 2004; 23: 159-171
Year: 2004
Immunosuppressive therapy after human lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105
Year: 2003
Basiliximab induction reduces the incidence of acute rejection in lung transplant patients
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab?
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015
Evaluation of early conversion to prolonged-release tacrolimus in lung transplantation.
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
LATE-BREAKING ABSTRACT: Long-term survival with extracorporeal photochemotherapy in lung transplant rejection patients not responsive to conventional treatment.
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Azithromycin (Azi) treatment for chronic allograft dysfunction after lung transplantation (LTx)
Source: Annual Congress 2003 - Bronchiolitis obliterans: diagnosis and treatment
Year: 2003
Effect of TLI during azithromycin treatment in patients with BOS after lung transplantation
Source: Eur Respir J 2007; 30: Suppl. 51, 174s
Year: 2007
Early sirolimus immunosuppression is safe in lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012
Mycophenolate mofetil reduces alveolar inflammation and acute rejection and improves overall outcome after lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006
Comparison of post renal transplant tuberculosis cases receiving conventional immunosupressive therapy and mycophenolat mofetil (MMF) and/or tacrolimus (TAC)
Source: Eur Respir J 2003; 22: Suppl. 45, 157s
Year: 2003
Treatment options in chronic GVHD and CLAD post lung transplantation
Source: International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities
Year: 2016
Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004
Mycophenolate mofetil (MMF) rescue therapy in lung transplantation: results and pharmacokinetics
Source: Eur Respir J 2002; 20: Suppl. 38, 348s
Year: 2002
A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011
Pulmonary graft-versus-host disease (GVHD) post- stem cell transplant (SCT) for haematological malignancies: Good response to treatment if diagnosed early
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
12 month follow-up of lung recipients with chronic allograft dysfunction treated with extracorporeal photopheresis (ECP)
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011
Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx)
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Azithromycin treatment in patients with BOS after lung transplantation
Source: ISSN=ISSN 1810-6838, ISBN=, page=178
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept